Skip to main content
. 2022 Sep 18;196(2):379–387. doi: 10.1007/s10549-022-06721-1

Fig. 1.

Fig. 1

Distribution of breast cancer subtypes defined by immunohistochemistry and tumour grade among 4,108 women born after 1965 who had breast cancer diagnosed in Scotland between 2009 and 2016. Luminal A-like (n = 1650), luminal B-like (HER2−) (n = 998), luminal B-like (HER2+). (n = 629), HER2-overexpressed (n = 214), Triple-negative (n = 617)